Correction (DOI:10.1016/j.jaad.2008.09.022);The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004

Journal of the American Academy of Dermatology

Volumn 60, Issue 2, 2009, Pages 218-224

  Kurd, Shanu Kohli ^a   Gelfand, Joel M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY SURFACE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES;

EID: 58149336900     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.06.068     Document Type: Erratum

References (32)

1. Azfar R.S., and Gelfand J.M. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 20 (2008) 416-422
2. Gelfand J.M., Troxel A.B., Lewis J.D., Kurd S.K., Shin D.B., Wang X., et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 143 (2007) 1493-1499
3. Gelfand J.M., Neimann A.L., Shin D.B., Wang X., Margolis D.J., and Troxel A.B. Risk of myocardial infarction in patients with psoriasis. JAMA 296 (2006) 1735-1741
4. Neimann A.L., Shin D.B., Wang X., Margolis D.J., Troxel A.B., and Gelfand J.M. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55 (2006) 829-835
5. Kurd S., Richardson S., and Gelfand J. An update on the epidemiology and systemic treatment of psoriasis. Expert Rev Clin Immunol 3 (2007) 171-185
6. Gelfand J.M., Azfar R.S., Shin D.B., Kurd S.K., Wang X., and Troxel A.B. Incidence of stroke in patients with psoriasis: a population-based study. J Invest Dermatol 128 (2008) S81
7. Pariser D.M., Bagel J., Gelfand J.M., Korman N.J., Ritchlin C.T., Strober B.E., and Van Voorhees A.S. National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 143 (2007) 239-242
8. Gelfand J.M. Long-term treatment for severe psoriasis: we're halfway there, with a long way to go. Arch Dermatol 143 (2007) 1191-1193
9. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 14 (1996) 485-496
10. Johnson M., and Roberts J. Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974. Vital Health Stat 11 (1978) 72
11. Nevitt G.J., and Hutchinson P.E. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 135 (1996) 533-537
12. Yip S.Y. The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol 10 (1984) 965-968
13. Gelfand J.M., Weinstein R., Porter S.B., Neimann A.L., Berlin J.A., and Margolis D.J. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 141 (2005) 1537-1541
14. Psoriasis H.L. A statistical, clinical and laboratory investigation of 255 psoriatics and matched healthy controls. Acta Derm Venereol 44 (1964) 191-207
15. Kavli G., Stenvold S.E., and Vandbakk O. Low prevalence of psoriasis in Norwegian lapps. Acta Derm Venereol 65 (1985) 262-263
16. Ferrandiz C., Bordas X., Garcia-Patos V., Puig S., Pujol R., and Smandia A. Prevalence of psoriasis in Spain (Epiderma Project: phase I). J Eur Acad Dermatol Venereol 15 (2001) 20-23
17. Lomholt G. Psoriasis on the Faroe Islands; a preliminary report. Acta Derm Venereol 34 (1954) 92
18. Barisic-Drusko V., Paljan D., Kansky A., and Vujasinovic S. Prevalence of psoriasis in Croatia. Acta Derm Venereol Suppl (Stockh) 146 (1989) 178-179
19. Brandrup F., and Green A. The prevalence of psoriasis in Denmark. Acta Derm Venereol 61 (1981) 344-346
20. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 3 (2004) 121-128
21. Falk E.S., and Vandbakk O. Prevalence of psoriasis in a Norwegian Lapp population. Acta Derm Venereol Suppl (Stockh) 182 (1993) 6-9
22. Rea J.N., Newhouse M.L., and Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med 30 (1976) 107-114
23. Gelfand J.M., Stern R.S., Nijsten T., Feldman S.R., Thomas J., Kist J., et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 52 (2005) 23-26
24. Stern R.S., Nijsten T., Feldman S.R., Margolis D.J., and Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9 (2004) 136-139
25. Neimann A.L., Porter S.B., and Gelfand J.M. The epidemiology of psoriasis. Expert Rev Dermatol 1 (2006) 63-75
26. Kavli G., Forde O.H., Arnesen E., and Stenvold S.E. Psoriasis: familial predisposition and environmental factors. Br Med J (Clin Res Ed) 291 (1985) 999-1000
27. Gelfand J.M., Feldman S.R., Stern R.S., Thomas J., Rolstad T., and Margolis D.J. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 51 (2004) 704-708
28. National Psoriasis Foundation. About psoriasis: statistics. Available at: http://www.psoriasis.org/about/stats/. Accessed November 6, 2008.
29. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
30. Gelfand J.M., Gladman D.D., Mease P.J., Smith N., Margolis D.J., Nijsten T., et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53 (2005) 573
31. Feldman S.R., Fleischer Jr. A.B., Reboussin D.M., Rapp S.R., Exum M.L., Clark A.R., et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 106 (1996) 183-186
32. Martin L.M., Leff M., Calonge N., Garrett C., and Nelson D.E. Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 18 (2000) 215-218